From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...

The Trump administration's freeze on communications, travel, and diversity efforts has sowed chaos across federal health ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

President Trump has ended the federal security detail for Anthony Fauci, the infectious disease expert who advised him on the ...

Deaths from cancer continue to fall in the United States, the American Cancer Society reported Thursday, but within that encouraging trend is a disturbing shift in the cancer burden from older to ...

"Our air conditioners have been controlling temperature and humidity, but maybe the air conditioners of tomorrow will also ...

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...

Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring ...

Scientists nationwide said the cancellation of NIH grant reviews has thrown early-career scientists into limbo ...

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...